Shiro Hinotsu

4.9k total citations
198 papers, 3.4k citations indexed

About

Shiro Hinotsu is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Shiro Hinotsu has authored 198 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Pulmonary and Respiratory Medicine, 68 papers in Surgery and 32 papers in Oncology. Recurrent topics in Shiro Hinotsu's work include Prostate Cancer Treatment and Research (50 papers), Prostate Cancer Diagnosis and Treatment (44 papers) and Bladder and Urothelial Cancer Treatments (44 papers). Shiro Hinotsu is often cited by papers focused on Prostate Cancer Treatment and Research (50 papers), Prostate Cancer Diagnosis and Treatment (44 papers) and Bladder and Urothelial Cancer Treatments (44 papers). Shiro Hinotsu collaborates with scholars based in Japan, United States and United Kingdom. Shiro Hinotsu's co-authors include Hideyuki Akaza, Mikio Namiki, Seiji Naito, Naoyuki Ochiai, Mika Hangai, Koji Kaneoka, Masataka Sakane, Toru Shimazui, Koji Kawai and Yasuo Ohashi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Shiro Hinotsu

183 papers receiving 3.3k citations

Peers

Countries citing papers authored by Shiro Hinotsu

Since Specialization

Citations

This map shows the geographic impact of Shiro Hinotsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Hinotsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Hinotsu more than expected).

Fields of papers citing papers by Shiro Hinotsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiro Hinotsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Hinotsu. The network helps show where Shiro Hinotsu may publish in the future.

Co-authorship network of co-authors of Shiro Hinotsu

This figure shows the co-authorship network connecting the top 25 collaborators of Shiro Hinotsu. A scholar is included among the top collaborators of Shiro Hinotsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiro Hinotsu. Shiro Hinotsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trends in uptake of cancer screening among people with severe mental illness before and after the COVID‐19 pandemic in Japan: A repeated cross‐sectional study 2025 ·Psychiatry and Clinical Neurosciences Reports ·(unknown), Masaki Fujiwara, Naoki Nakaya, Koji Otsuki, Taichi Shimazu, Maiko Fujimori, Shiro Hinotsu, (unknown), Yosuke Uchitomi, Masatoshi Inagaki	0
2	Maternal age and the rising incidence of hypertensive disorders of pregnancy: A comprehensive analysis of national claims data from Japan 2025 ·PLoS ONE ·Naomi Maeda, Masayuki Koyama, (unknown), (unknown), Nobuaki Himuro, Tasuku Mariya, (unknown), Shiro Hinotsu, Tsuyoshi Saito, Hirofumi Ohnishi	1
3	Estimating the Optimal COVID-19 Booster Timing Using Surrogate Correlates of Protection: A Longitudinal Antibody Study in Naïve and Previously Infected Individuals 2025 ·Pathogens ·Yoshihiro Fujiya, Ryo Kobayashi, Makito Tanaka, (unknown), Shiro Hinotsu, (unknown), Yuki Sato, (unknown), (unknown), (unknown), (unknown), (unknown), Koji Kuronuma, Satoshi Takahashi	0
4	Early recovery of urinary continence after robot‐assisted radical prostatectomy is associated with membranous urethra and neurovascular bundle preservation 2024 ·International Journal of Urology ·Satoshi Ando, Toru Sugihara, Shiro Hinotsu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Kaori Endo, Jun Kamei, Eiichiro Takaoka, Tetsuya Fujimura	5
5	Changes in the trends of initial treatment for newly diagnosed prostate cancer in Japan: a nationwide multi-institutional study 2024 ·Japanese Journal of Clinical Oncology ·Taketo Kawai, Mizuki Onozawa, Satoru Taguchi, Masaki Shiota, Shinichi Sakamoto, Yoshiyuki Yamamoto, Yasuhide Kitagawa, Tohru Nakagawa, Shiro Hinotsu, (unknown), (unknown)	4
6	The effect of lemborexant on insomnia in patients with psychiatric disorders: Detailed evaluation using the Athens Insomnia Scale 2024 ·SHILAP Revista de lepidopterología ·Tomonori Murayama, Yuji Ito, (unknown), (unknown), Shiro Hinotsu, Masahiko Fujita	2
7	Pharmacotherapy for patients with calcium oxalate stones and abnormal urine chemistry: A systematic review and meta‐analysis for the Japanese Clinical Practice Guidelines for the Management of Urinary Stones, Third Edition 2024 ·International Journal of Urology ·Yasuo Kohjimoto, Akinori Iba, Shimpei Yamashita, Masatoshi Higuchi, (unknown), (unknown), Shiro Hinotsu, Satoshi Yamaguchi, Katsuhito Miyazawa, Isao Hara	1
8	Perceptions toward issues in cancer care for people with mental illness among psychiatric care providers: A questionnaire study 2023 ·Psycho-Oncology ·Yuto Yamada, Masaki Fujiwara, (unknown), (unknown), Shin‐ichiro Inoue, (unknown), Masafumi Kodama, (unknown), (unknown), (unknown), Maiko Fujimori, Taichi Shimazu, Naoki Nakaya, Shiro Hinotsu, Masahiro Tabata, (unknown), Yosuke Uchitomi, Norihito Yamada, (unknown), Masatoshi Inagaki	0
9	Population-Based Observational Study of Adverse Drug Event-Related Mortality in the Super-Aged Society of Japan 2021 ·Drug Safety ·(unknown), Toshihiro Koyama, Hideharu Hagiya, Ko Harada, (unknown), Soichiro Ushio, Yoshito Zamami, Takahiro Niimura, Kazuaki Shinomiya, Keisuke Ishizawa, Toshiaki Sendo, Shiro Hinotsu, Mitsunobu R. Kano	4
10	Encouraging participation in colorectal cancer screening for people with schizophrenia: A randomized controlled trial 2021 ·Acta Psychiatrica Scandinavica ·Masaki Fujiwara, Yuto Yamada, Taichi Shimazu, Masafumi Kodama, Ryuhei So, (unknown), (unknown), (unknown), Maiko Fujimori, Hirokazu Takahashi, Naoki Nakaya, (unknown), Tempei Miyaji, Shiro Hinotsu, Keita Harada, Hiroyuki Okada, Yosuke Uchitomi, Norihito Yamada, Masatoshi Inagaki	16
11	Place of death trends among patients with dementia in Japan: a population-based observational study 2019 ·Scientific Reports ·Toshihiro Koyama, (unknown), Hideharu Hagiya, Yoshito Zamami, (unknown), (unknown), (unknown), (unknown), Kazuaki Shinomiya, Yoshihisa Kitamura, Toshiaki Sendo, Shiro Hinotsu, Mitsunobu R. Kano	16
12	A randomised controlled trial of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia in psychiatric outpatient clinics: study protocol for the J-SUPPORT 1901 (ACCESS) study 2019 ·BMJ Open ·Masaki Fujiwara, Masatoshi Inagaki, Taichi Shimazu, Masafumi Kodama, Ryuhei So, (unknown), (unknown), (unknown), Maiko Fujimori, Hirokazu Takahashi, Naoki Nakaya, (unknown), Tempei Miyaji, Shiro Hinotsu, Keita Harada, Hiroyuki Okada, Yosuke Uchitomi, Norihito Yamada	6
13	Trastuzumab Emtansine in HER2+ Recurrent Metastatic Non–Small-Cell Lung Cancer: Study Protocol 2016 ·Clinical Lung Cancer ·Kadoaki Ohashi, Katsuyuki Hotta, Taizo Hirata, Keisuke Aoe, Toshiyuki Kozuki, Kiichiro Ninomiya, Hiroe Kayatani, Hiroyuki Yanai, Shinichi Toyooka, Shiro Hinotsu, Minoru Takata, Katsuyuki Kiura	16
14	A Survey of Physicians^\|^apos; Understanding of the Regulatory Systems for Clinical Trials in Japan 2013 ·(unknown), (unknown), Hisashi Urushihara, (unknown), Yasutoshi Kobayashi, Shiro Hinotsu, Masao Nakagawa, Koji Kawakami	0
15	Clinical guidelines in Japan (The 49th annual meeting of Japanese Society of Clinical Oncology educational book) -- (JSCO University: Urological cancers) 2011 ·Shiro Hinotsu	1
16	Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract: A single institutional retrospective long‐term follow‐up study 2010 ·International Journal of Urology ·Eiichiro Takaoka, Shiro Hinotsu, Akira Joraku, Takehiro Oikawa, Noritoshi Sekido, Naoto Miyanaga, Koji Kawai, Toru Shimazui, Hideyuki Akaza	17
17	Prediction of in vitro response to interferon‐α in renal cell carcinoma cell lines 2007 ·Cancer Science ·Toru Shimazui, (unknown), Kazuhiro Yoshikawa, Kazuhiko Uchida, Takahiro Kojima, Takehiro Oikawa, Kogenta Nakamura, Nobuaki Honda, Shiro Hinotsu, Jun Miyazaki, (unknown), Hideyuki Akaza	3
18	Efficacy of Dose-intensified MEC (Methotrexate, Epirubicin and Cisplatin) Chemotherapy for Advanced Urothelial Carcinoma: a Prospective Randomized Trial Comparing MEC and M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) 1998 ·Japanese Journal of Clinical Oncology ·M. Kuroda, T Kotake, Hideyuki Akaza, Shiro Hinotsu, Tadao Kakizoe	36
19	Comparison of clinical effects between granisetron alone and combination of granisetron and methylprednisolone against the nausea and vomiting induced by CDDP chemotherapy comparative study by the cross-over trial 1996 ·Gan to kagaku ryōhō ·Yuusuke Uchida, Hideyuki Akaza, Toru Shimazui, Koji Kikuchi, (unknown), Akiko Iwasaki, Satoshi Ishikawa, (unknown), (unknown), Kazunori Hattori, (unknown), (unknown), Kosuke Sato, Kenkichi Koiso, Shiro Hinotsu	2
20	Primary signet ring cell carcinoma of the bladder effectively treated with intra-arterial chemotherapy and radiation therapy: A case report 1995 ·Takashi Ota, Toru Shimazui, Shiro Hinotsu, Hideyuki Akaza, Kenkichi Koiso, (unknown), Takesaburo Ogata	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact